Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 35.00
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
TPE:1762 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,692 | 1,884 | 2,629 | 4,452 | 5,088 | 5,034 | |
Market Cap Growth | 24.33% | -28.33% | -40.94% | -12.50% | 1.08% | 5.53% |
Enterprise Value | 3,116 | 2,437 | 3,440 | 5,370 | 5,431 | 5,583 |
Last Close Price | 35.00 | 24.50 | 33.67 | 56.14 | 63.10 | 61.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 49.58 | 16.81 | 10.92 | 12.56 |
Forward PE | - | 17.28 | 17.28 | 8.11 | 10.40 | 7.96 |
PS Ratio | 2.88 | 2.34 | 1.95 | 2.13 | 2.40 | 2.60 |
PB Ratio | 0.84 | 0.61 | 0.78 | 1.33 | 1.59 | 1.74 |
P/TBV Ratio | 0.84 | 0.61 | 0.78 | 1.33 | 1.60 | 1.74 |
P/FCF Ratio | 10.78 | 23.20 | 7.21 | - | 14.17 | - |
P/OCF Ratio | 9.23 | 13.21 | 5.62 | - | 6.93 | 22.97 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.34 | 3.03 | 2.55 | 2.57 | 2.57 | 2.89 |
EV/EBITDA Ratio | 23.39 | - | 16.74 | 11.33 | 8.59 | 9.79 |
EV/EBIT Ratio | - | - | 542.43 | 19.13 | 11.72 | 12.73 |
EV/FCF Ratio | 12.48 | 30.00 | 9.44 | - | 15.12 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.24 | 0.26 | 0.26 | 0.36 | 0.19 | 0.26 |
Debt / EBITDA Ratio | 14.58 | - | 4.17 | 2.55 | 0.95 | 1.32 |
Debt / FCF Ratio | 3.02 | 9.90 | 2.35 | - | 1.68 | - |
Net Debt / Equity Ratio | 0.13 | 0.19 | 0.19 | 0.28 | 0.10 | 0.19 |
Net Debt / EBITDA Ratio | 8.48 | -4.59 | 3.09 | 1.98 | 0.48 | 0.98 |
Net Debt / FCF Ratio | 1.70 | 7.24 | 1.74 | -1.82 | 0.84 | -3.02 |
Asset Turnover | 0.21 | 0.18 | 0.27 | 0.43 | 0.47 | 0.51 |
Inventory Turnover | 1.05 | 0.97 | 0.87 | 1.31 | 1.47 | 1.60 |
Quick Ratio | 1.77 | 0.94 | 1.01 | 0.63 | 1.00 | 0.93 |
Current Ratio | 4.06 | 2.97 | 3.39 | 2.15 | 2.36 | 2.14 |
Return on Equity (ROE) | -1.60% | -7.57% | 1.58% | 8.10% | 15.32% | 14.87% |
Return on Assets (ROA) | -1.91% | -4.40% | 0.08% | 3.60% | 6.48% | 7.28% |
Return on Invested Capital (ROIC) | -3.73% | -8.33% | 0.14% | 5.73% | 10.66% | 12.18% |
Return on Capital Employed (ROCE) | -3.30% | -8.10% | 0.10% | 6.50% | 11.70% | 11.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.92% | -12.94% | 2.02% | 5.95% | 9.16% | 7.96% |
FCF Yield | 9.27% | 4.31% | 13.87% | -11.60% | 7.06% | -3.66% |
Dividend Yield | 0.53% | - | 0.56% | 1.43% | 2.06% | 2.13% |
Payout Ratio | - | - | 117.00% | 38.06% | 21.64% | 29.03% |
Buyback Yield / Dilution | -22.69% | 1.27% | 27.92% | 0.52% | -0.23% | 0.02% |
Total Shareholder Return | -22.16% | 1.27% | 28.48% | 1.94% | 1.83% | 2.15% |